PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 19 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic extracts demonstrated potential to inhibit growth and proliferation by modulating genes related to apoptosis [PMID:37894369, 37242800]
Crude extracts showed complete inhibition of Candida albicans growth on solid media [PMID:20606782]
Methanolic extracts inhibited growth of M. fortuitum, M. smegmatis, and M. kansasii [PMID:21772752]
Treated chickens showed reduced mortality rates and milder clinical signs during the acute phase [PMID:11849832]
Treatment resulted in delayed occurrence of clinical signs, reduced disease severity, and lower mortality rates (14.2% in treated vs 42.8% in untreated) [PMID:11849835]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37242800 (2023) — Pharmacotherapeutic Potential of Aloe secundiflora against Colorectal Cancer Growth and Proliferation. · Pharmaceutics
- 2.PMID: 20606782 (2009) — The efficacy of crude extract of Aloe secundiflora on Candida albicans. · African journal of traditional, complementary, and alternative medicines : AJTCAM
- 3.PMID: 37894369 (2023) — Modulatory Properties of Aloe secundiflora's Methanolic Extracts on Targeted Genes in Colorectal Cancer Management. · Cancers
- 4.PMID: 28315138 (2017) — Anticoccidial effects of Aloe secundiflora leaf extract against Eimeria tenella in broiler chicken. · Tropical animal health and production
- 5.PMID: 21772752 (2011)